Poly Medicure Ltd.

NSE: POLYMED BSE: 531768 SECTOR: Medical Equipment/Supplies/Accessories  41k   402   58

977.70
+2.55 (0.26%)
NSE: Today, 03:48 PM

Price Summary

Today's High

₹ 983.95

Today's Low

₹ 957.05

52 Week High

₹ 1060

52 Week Low

₹ 651.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9377.91 Cr.

Enterprise Value

9478.94 Cr.

No. of Shares

9.59 Cr.

P/E

63.94

P/B

8.32

Face Value

₹ 5

Div. Yield

0.25 %

Book Value (TTM)

₹  117.58

CASH

8.31 Cr.

DEBT

109.34 Cr.

Promoter Holding

53.33 %

EPS (TTM)

₹  15.29

Sales Growth

17.66%

ROE

14.4 %

ROCE

17.68%

Profit Growth

12.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.66%
3 Year14.44%
5 Year14.88%

Profit Growth

1 Year12.74%
3 Year30.12%
5 Year21.04%

ROE%

1 Year14.4%
3 Year18.66%
5 Year19.57%

ROCE %

1 Year17.68%
3 Year21.31%
5 Year22.56%

Debt/Equity

0.1017

Price to Cash Flow

74.27

Interest Cover Ratio

37.3010309662745

CFO/PAT (5 Yr. Avg.)

1.10678858463367

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2022 53.33 0
Jun 2022 53.34 0
Mar 2022 44.66 0
Dec 2021 44.76 0
Sep 2021 44.77 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.116354920545% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 21.3142531084847% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 37.3010309662745.
  • The Company has been maintaining an effective average operating margins of 24.7979023169059% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 30.3668221168218 days.
  • Company has a healthy liquidity position with current ratio of 3.64533398139831.
  • The company has a good cash flow management; CFO/PAT stands at 1.10678858463367.
  • The company has a high promoter holding of 53.33%.

 Limitations

  • The company has shown a poor revenue growth of 14.4420130467595% for the Past 3 years.
  • The company is trading at a high PE of 63.94.
  • The company is trading at a high EV/EBITDA of 37.7855.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
Net Sales 211.93 220.05 244.44 239.01 263.99
Total Expenditure 161.48 169.16 187.59 190.81 197.71
Operating Profit 50.46 50.89 56.85 48.2 66.28
Other Income 12.29 7.17 9 4.58 8.71
Interest 0.03 -0.75 1.3 1.07 0.29
Depreciation 13.19 13.27 13.53 13.58 13.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 49.53 45.53 51.02 38.13 60.97
Tax 12.19 11.33 12.58 9.33 15.75
Profit After Tax 37.34 34.21 38.44 28.8 45.22
Adjusted EPS (Rs) 3.89 3.57 4.01 3 4.71

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 508.44 586.69 646.16 747.38 879.36
Total Expenditure 386.94 452.71 483.92 537.03 665.47
Operating Profit 121.5 133.98 162.24 210.36 213.89
Other Income 14.37 16.05 18.58 19.29 38.73
Interest 11.11 13.18 19.76 9.95 5.36
Depreciation 28.41 36.36 39.28 46.31 52.54
Exceptional Items 0 0 0 0 0
Profit Before Tax 96.36 100.49 121.78 173.38 194.72
Tax 26.16 34.21 29.4 43.87 48.7
Net Profit 70.2 66.28 92.38 129.51 146.02
Adjusted EPS (Rs.) 7.96 7.51 10.47 13.51 15.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 44.11 44.12 44.12 47.94 47.95
Total Reserves 290.4 335.66 385.16 906.07 1029.02
Borrowings 79.12 91.38 110.57 59.74 30.56
Other N/C liabilities 24.83 26.96 23.92 21.67 23.15
Current liabilities 116.18 162.44 208.27 195.54 203.27
Total Liabilities 554.64 660.56 772.05 1230.96 1333.96
Assets
Net Block 256.09 268.54 324.16 384.97 447.46
Capital WIP 9.66 9.29 16.7 14.74 37.11
Intangible WIP 8.58 9.24 7.88 6.43 5.86
Investments 11.19 45.55 45.49 39.8 46.94
Loans & Advances 13.7 8.82 19.54 12.73 31.85
Other N/C Assets 5.6 10.39 32.88 55.06 23.75
Current Assets 249.81 308.73 325.4 717.23 740.99
Total Assets 554.64 660.56 772.05 1230.96 1333.96
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 96.36 100.49 121.78 173.38 194.72
Adjustment 37.78 40.93 50.36 44.94 38.6
Changes in Assets & Liabilities -35.5 -0.74 -9.66 -57.79 -60.19
Tax Paid -23.14 -27.49 -35.58 -44.14 -46.86
Operating Cash Flow 75.5 113.19 126.91 116.4 126.26
Investing Cash Flow -87.07 -104.27 -105.67 -434.41 -88.71
Financing Cash Flow 14.48 -9.69 -22.25 318.92 -39.71
Net Cash Flow 2.91 -0.77 -1.02 0.9 -2.16

Corporate Actions

Investors Details

PARTICULARS Sep 2021% Dec 2021% Mar 2022% Jun 2022% Sep 2022%
Promoters 44.77 44.76 44.66 53.34 53.33
rishi baid 10.42 10.42 10.32 10.32 10.31
himanshu baid 8.25 8.25 8.25 8.25 8.24
zetta matrix consu... - - - 8.68 8.68
himanshu baid(huf) - - - - -
himanshu baid (huf) 4.00 - - - -
vcb trading llp 3.69 3.69 3.69 3.69 3.69
himanshu baid huf - 4.00 4.00 4.00 4.00
jai polypan pvt. l... - - - - 3.49
jai polypan pvt ltd - 3.50 3.50 3.50 -
jai polypan privat... 3.50 - - - -
jai polypan pvt. l... - - - - -
mukulika baid 3.19 3.19 3.19 3.19 -
smt mukulika baid - - - - -
smt. mukulika baid - - - - 3.19
rishi baid(huf) - - - - -
rishi baid (huf) 2.90 - - - -
rishi baid huf - 2.90 2.90 2.90 2.90
jugal kishore baid 2.38 2.38 2.38 2.38 2.38
vishal baid 1.75 1.75 1.75 1.75 1.75
shailey baid 1.24 - - - -
shireen baid 1.17 1.17 1.17 1.17 1.17
shaily baid - 1.24 1.24 1.24 1.24
neha baid 1.07 1.07 1.07 1.07 1.07
dhruv baid 0.38 0.38 0.38 0.38 0.38
aaryaman baid 0.29 0.29 0.29 0.29 0.29
arham baid 0.29 0.29 0.29 0.29 0.29
madhu kothari 0.18 0.18 0.18 0.18 0.18
vinay kothari 0.06 0.06 0.06 0.06 0.06
polycure martech l... 0.01 0.01 0.01 0.01 0.01
PARTICULARS Sep 2021% Dec 2021% Mar 2022% Jun 2022% Sep 2022%
Investors 55.23 55.24 55.34 46.66 46.67
ezekiel global bus... 12.89 12.89 12.89 12.89 12.89
zetta matrix consu... 8.68 8.68 8.68 - -
matthews india fund - - - - -
smallcap world fun... 4.70 4.70 4.70 4.70 -
small cap world fu... - - - - 4.70
lighthouse india i... 3.73 3.73 4.28 4.29 4.29
scg & co llp - - - - -
uti- healthcare fu... - - - - 2.90
uti healthcare fund - 2.54 2.83 2.87 -
nirajkumar vinodku... - - - - -
uti - healthcare f... 2.35 - - - -
nilaykumar vinodku... 2.07 2.07 2.07 2.07 2.07
ashish kacholia 1.67 1.56 - - -
nirmala vinodkumar... - - - - -
varun daga 1.63 1.62 1.62 1.62 1.62
shreans daga 1.23 1.22 1.22 1.22 1.22
kjmc financial ser... - - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ3FY21 8 Feb 2021
  • PresentationQ4FY22 27 May 2022
  • PresentationQ4FY21 26 May 2021

Poly Medicure Stock Price Analysis and Quick Research Report. Is Poly Medicure an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Poly Medicure and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 126.2646 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Poly Medicure has a Debt to Equity ratio of 0.1017 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Poly Medicure , the EPS growth was 12.7209867037816 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Poly Medicure has OPM of 24.3234834156207 % which is a good sign for profitability.
     
  • ROE: Poly Medicure have a average ROE of 14.3953355899158 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Poly Medicure

X